Home / Inspections / 1148403

FDA Inspection 1148403 — Hisun Pharmaceutical Hangzhou Co., Ltd

Hisun Pharmaceutical Hangzhou Co., Ltd — FEI 3008481334

The FDA completed an inspection of Hisun Pharmaceutical Hangzhou Co., Ltd on July 20, 2021 in Hangzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 20, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hangzhou (China)

Facility

Other inspections at this facility

  • 1236569 (VAI Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1079698 (NAI Fri Jan 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1044032 (VAI Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 992914 (OAI Thu Oct 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 883564 (VAI Fri Apr 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources